- Home
- EMX vs TSVT Comparison
EMX vs TSVT Comparison
Compare EMX & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMX
- TSVT
- Stock Information
- Founded
- EMX N/A
- TSVT 2021
- Country
- EMX Canada
- TSVT United States
- Employees
- EMX N/A
- TSVT N/A
- Industry
- EMX
- TSVT Biotechnology: Pharmaceutical Preparations
- Sector
- EMX
- TSVT Health Care
- Exchange
- EMX Nasdaq
- TSVT Nasdaq
- Market Cap
- EMX 190.7M
- TSVT 160.4M
- IPO Year
- EMX N/A
- TSVT N/A
- Fundamental
- Price
- EMX $1.71
- TSVT $3.09
- Analyst Decision
- EMX Strong Buy
- TSVT Buy
- Analyst Count
- EMX 1
- TSVT 6
- Target Price
- EMX $7.00
- TSVT $10.40
- AVG Volume (30 Days)
- EMX 235.3K
- TSVT 245.3K
- Earning Date
- EMX 11-07-2024
- TSVT 11-12-2024
- Dividend Yield
- EMX N/A
- TSVT N/A
- EPS Growth
- EMX N/A
- TSVT N/A
- EPS
- EMX N/A
- TSVT N/A
- Revenue
- EMX $26,818,000.00
- TSVT $45,620,000.00
- Revenue This Year
- EMX N/A
- TSVT N/A
- Revenue Next Year
- EMX $13.85
- TSVT $36.09
- P/E Ratio
- EMX N/A
- TSVT N/A
- Revenue Growth
- EMX 25.53
- TSVT N/A
- 52 Week Low
- EMX $1.41
- TSVT $2.90
- 52 Week High
- EMX $2.15
- TSVT $6.40
- Technical
- Relative Strength Index (RSI)
- EMX 42.69
- TSVT 34.33
- Support Level
- EMX $1.70
- TSVT $3.17
- Resistance Level
- EMX $1.81
- TSVT $4.07
- Average True Range (ATR)
- EMX 0.04
- TSVT 0.22
- MACD
- EMX 0.00
- TSVT -0.03
- Stochastic Oscillator
- EMX 25.06
- TSVT 0.62
About EMX EMX Royalty Corporation (Canada)
EMX Royalty Corp and its subsidiaries operate as a royalty and prospect generator engaged in exploring for and generating royalties from, metals and minerals properties. The company is a precious, and base metals royalty company. The Company augments royalty generation with royalty acquisitions and strategic investments. EMX's royalty and mineral property portfolio consists of properties in North America, Europe, Turkiye, Latin America, Morocco, and Australia.
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.